Product Recalls in New York

Product recalls affecting New York — including food, drugs, consumer products, medical devices, and vehicles distributed to New York. RecallDetector monitors distribution data from the FDA, USDA, CPSC, and NHTSA to show you which recalls are relevant to your area. 2,901 recalls have been distributed to New York in the last 12 months.

55,896 total recalls
2,901 in last 12 months

Showing 561580 of 13,591 recalls

DrugApril 18, 2025· American Regent, Inc.

Recalled Item: niCARdipine Hydrochloride Injection Recalled by American Regent, Inc. Due to...

The Issue: Lack of sterility assurance: Product leakage around the vial neck, which...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 18, 2025· American Regent, Inc.

Recalled Item: niCARdipine Hydrochloride Injection Recalled by American Regent, Inc. Due to...

The Issue: Lack of sterility assurance: Product leakage around the vial neck, which...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 18, 2025· Preferred Pharmaceuticals, Inc.

Recalled Item: Clindamycin Hydrochloride Capsules Recalled by Preferred Pharmaceuticals,...

The Issue: cGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 17, 2025· Amneal Pharmaceuticals, LLC

Recalled Item: Ropivacaine Hydrochloride Injection Recalled by Amneal Pharmaceuticals, LLC...

The Issue: Presence of Particulate Matter

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund
DrugApril 15, 2025· OurPharma LLC

Recalled Item: HYDROmorphone Hydrochloride 50mg/50mL (1mg/mL) Recalled by OurPharma LLC Due...

The Issue: Superpotent Drug: Assay/potency result for hydromorphone HCl in the...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugApril 14, 2025· SAINI TRADE INC

Recalled Item: ELECTRO BUZZ Recalled by SAINI TRADE INC Due to Undeclared Chloropretadalafil

The Issue: Marketed without an Approved NDA/ANDA: Laboratory analysis found the product...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund
DrugApril 14, 2025· SAINI TRADE INC

Recalled Item: ULTRA ARMOR Recalled by SAINI TRADE INC Due to Undeclared...

The Issue: Marketed without an Approved NDA/ANDA: Laboratory analysis found the product...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund
DrugApril 14, 2025· SAINI TRADE INC

Recalled Item: Male Ultra Pro Recalled by SAINI TRADE INC Due to Undeclared...

The Issue: Marketed without an Approved NDA/ANDA: Laboratory analysis found the product...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund
DrugApril 14, 2025· SAINI TRADE INC

Recalled Item: MALEXTRA Recalled by SAINI TRADE INC Due to Undeclared Propoxyphenylsildenafil

The Issue: Marketed without an Approved NDA/ANDA: Laboratory analysis found the product...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund
DrugApril 14, 2025· SAINI TRADE INC

Recalled Item: Male Ultra Recalled by SAINI TRADE INC Due to Undeclared Propoxyphenylsildenafil

The Issue: Marketed without an Approved NDA/ANDA: Laboratory analysis found the product...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund
DrugApril 14, 2025· Breckenridge Pharmaceutical, Inc

Recalled Item: Duloxetine Delayed-Release Capsules USP Recalled by Breckenridge...

The Issue: CGMP Deviations: Presence of Nitrosamine Drug Substance Related Impurity...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 14, 2025· Breckenridge Pharmaceutical, Inc

Recalled Item: Duloxetine Delayed-Release Capsules USP Recalled by Breckenridge...

The Issue: CGMP Deviations: Presence of Nitrosamine Drug Substance Related Impurity...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 14, 2025· The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories

Recalled Item: ChlorproMAZINE Hydrochloride Tablets Recalled by The Harvard Drug Group LLC...

The Issue: CGMP deviations: presence of N-Nitroso-Desmethyl Chlorpromazine impurity...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 10, 2025· ACCORD HEALTHCARE, INC.

Recalled Item: Levothyroxine Sodium Tablets Recalled by ACCORD HEALTHCARE, INC. Due to...

The Issue: Subpotent

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 10, 2025· ACCORD HEALTHCARE, INC.

Recalled Item: Levothyroxine Sodium Tablets Recalled by ACCORD HEALTHCARE, INC. Due to...

The Issue: Subpotent

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 10, 2025· ACCORD HEALTHCARE, INC.

Recalled Item: Levothyroxine Sodium Tablets Recalled by ACCORD HEALTHCARE, INC. Due to...

The Issue: Subpotent

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 10, 2025· ACCORD HEALTHCARE, INC.

Recalled Item: Levothyroxine Sodium Tablets Recalled by ACCORD HEALTHCARE, INC. Due to...

The Issue: Subpotent

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 10, 2025· Lupin Pharmaceuticals Inc.

Recalled Item: clomiPRAMINE hydrochloride Capsules USP Recalled by Lupin Pharmaceuticals...

The Issue: Failed Impurities/Degradation Specifications: an out of specification result...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 10, 2025· Eugia US LLC

Recalled Item: Testosterone Cypionate Injection Recalled by Eugia US LLC Due to cGMP:...

The Issue: cGMP: complaints of crystals not redissolving into solution after warming...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 3, 2025· Zydus Pharmaceuticals (USA) Inc

Recalled Item: chlorproMAZINE Hydrochloride Tablets Recalled by Zydus Pharmaceuticals (USA)...

The Issue: CGMP deviations: presence of N-Nitroso-Desmethyl Chlorpromazine impurity...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund